Nasser Zawia


Nasser H. Zawia was a former dean and the inaugural director of the Interdisciplinary Neuroscience Program (INP) at the University of Rhode Island. He played a co-founding role in the formation of the George and Anne Ryan Institute for Neuroscience.

Marwan Sabbagh

Chief Medical Officer

Dr. Sabbagh is the Camille and Larry Ruvo Endowed Chair for Brain Health and Director of Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. Dr Sabbagh has dedicated his career to finding a cure for Alzheimer’s and other age-related neurodegenerative diseases.

Daniel Brennan

Chief Business and Operating Officer

Mr. Brennan most recently served as the Chief Commercial Officer at Catalyst Pharmaceuticals (NASDAQ: CPRX) and Chief Operating Officer at Edge Therapeutics (NASDAQ: EDGE) where he was responsible for pre-commercialization and launch activities of the company’s lead products targeting rare neurological conditions.

NeuroTau, Inc. is a biotech company, formed in 2017, that focuses on developing drugs that target the disruption or decay of the important neurobiological protein called Tau

Contact Us

Close Bitnami banner